{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:01:48Z","timestamp":1780498908141,"version":"3.54.1"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Over 16\u00a0million children have been detected positive for the coronavirus disease 2019 (COVID-19) in the United States since the outbreak of the pandemic. In general, children infected with severe acute respiratory syndrome coronavirus type 2 tend to have lighter symptoms than adults. However, in some cases, the infection can develop into severe forms, such as multisystem inflammatory syndrome in children. Moreover, long-term public health preventive interventions have had some negative effects on the physical and mental health of children. Given the important role that vaccination plays in reducing severe illness and mortality, it is essential for the efficient implementation of vaccination in the pediatric population. Nevertheless, parental distrust of vaccination, especially with regard to its safety and efficacy, hinders this process. Herein, we comprehensively summarize the available data on the safety and effectiveness of COVID-19 vaccine in children. The results show that the currently approved COVID-19 vaccine is safe and effective for children. Although two doses of vaccine in children seem insufficient to prevent Omicron infection, the booster dose provides enhanced protection against infection and severe illness. Most importantly, the bivalent vaccine has been approved for use in the pediatric population to extend the immune response to currently circulating Omicron variant. And the immune protection afforded to newborns after maternal vaccination appears to last only 6 months. Therefore, in the current situation where the rate of virus mutation is accelerating and the COVID-19 pandemic is still severe, it is crucial to extend vaccine protection to children over 6 months of age to weave a tighter safety net.<\/jats:p>","DOI":"10.1186\/s13052-023-01513-9","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T23:03:01Z","timestamp":1692918181000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Dilemmas and options for COVID-19 vaccination in children"],"prefix":"10.1186","volume":"49","author":[{"given":"Jingzhi","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shungeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziteng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changqing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9109-9162","authenticated-orcid":false,"given":"Jianing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0673-3163","authenticated-orcid":false,"given":"Shiheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,25]]},"reference":[{"key":"1513_CR1","unstructured":"World Health Organization. Coronavirus disease (COVID-19). https:\/\/www.who.int\/health-topics\/coronavirus#tab=tab_3"},{"key":"1513_CR2","unstructured":"World Health Organization. WHO Coronavirus (COVID-19) dashboard. https:\/\/covid19.who.int\/"},{"key":"1513_CR3","doi-asserted-by":"publisher","unstructured":"Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. Apr 2020;323(13):1239\u20131242. https:\/\/doi.org\/10.1001\/jama.2020.2648","DOI":"10.1001\/jama.2020.2648"},{"issue":"4","key":"1513_CR4","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","volume":"46","author":"H Zhang","year":"2020","unstructured":"Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46(4):586\u201390.","journal-title":"Intensive Care Med"},{"key":"1513_CR5","unstructured":"Centers for Disease Control and Prevention. Demographic Trends of COVID-19 cases and deaths in the US reported to CDC. https:\/\/covid.cdc.gov\/covid-data-tracker\/#demographics"},{"key":"1513_CR6","unstructured":"Centers for Disease Control and Prevention. COVID data tracker. https:\/\/covid.cdc.gov\/covid-data-tracker\/#new-hospital-admissions"},{"key":"1513_CR7","doi-asserted-by":"crossref","unstructured":"DeBiasi RL, Song X, Delaney M, Bell M, Smith K, Pershad J et al. Severe coronavirus disease-2019 in children and young adults in the Washington, DC, metropolitan region, J Pediatr, vol. 223, pp. 199\u2013203. e1, 2020.","DOI":"10.1016\/j.jpeds.2020.05.007"},{"issue":"4","key":"1513_CR8","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1056\/NEJMoa2021680","volume":"383","author":"LR Feldstein","year":"2020","unstructured":"Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, et al. Multisystem inflammatory syndrome in US children and adolescents. N Engl J Med. 2020;383(4):334\u201346.","journal-title":"N Engl J Med"},{"issue":"3","key":"1513_CR9","doi-asserted-by":"publisher","first-page":"e0242587","DOI":"10.1371\/journal.pone.0242587","volume":"16","author":"B Rumain","year":"2021","unstructured":"Rumain B, Schneiderman M, Geliebter A. Prevalence of COVID-19 in adolescents and youth compared with older adults in states experiencing surges. PLoS ONE. 2021;16(3):e0242587. https:\/\/doi.org\/10.1371\/journal.pone.0242587","journal-title":"PLoS ONE"},{"key":"1513_CR10","doi-asserted-by":"publisher","unstructured":"Szablewski CM, Chang KT, Brown MM, Chu VT, Yousaf AR, Anyalechi N, et al. SARS-CoV-2 transmission and infection among attendees of an overnight Camp - Georgia, June 2020. MMWR Morb Mortal Wkly Rep. Aug 2020;69(31):1023\u20135. https:\/\/doi.org\/10.15585\/mmwr.mm6931e1","DOI":"10.15585\/mmwr.mm6931e1"},{"key":"1513_CR11","doi-asserted-by":"publisher","unstructured":"Lopez-Bueno R, Lopez-Sanchez GF, Casajus JA, Calatayud J, Tully MA, Smith L. Potential health-related behaviors for pre-school and school-aged children during COVID-19 lockdown: a narrative review. Prev Med. Feb 2021;143:106349. https:\/\/doi.org\/10.1016\/j.ypmed.2020.106349","DOI":"10.1016\/j.ypmed.2020.106349"},{"key":"1513_CR12","doi-asserted-by":"publisher","unstructured":"McKune SL, Acosta D, Diaz N, Brittain K, Beaulieu DJ, Maurelli AT, et al. Psychosocial health of school-aged children during the initial COVID-19 safer-at-home school mandates in Florida: a cross-sectional study. BMC Public Health. Mar 29 2021;21(1):603. https:\/\/doi.org\/10.1186\/s12889-021-10540-2","DOI":"10.1186\/s12889-021-10540-2"},{"key":"1513_CR13","unstructured":"Public Health Agency of Canada. COVID-19 vaccination coverage. https:\/\/www.canada.ca\/en\/public-health\/services\/diseases\/coronavirus-disease-covid-19.html"},{"key":"1513_CR14","unstructured":"Centers for Disease Control and Prevention. Trends in demographic characteristics of people receiving COVID-19 vaccinations in the United States. https:\/\/covid.cdc.gov\/covid-data-tracker\/#vaccination-demographics-trends"},{"key":"1513_CR15","doi-asserted-by":"publisher","unstructured":"Byrne A, Thompson LA, Filipp SL, Ryan K. COVID-19 vaccine perceptions and hesitancy amongst parents of school-aged children during the pediatric vaccine rollout. Vaccine. Nov 2022;40(46):6680\u20136687. https:\/\/doi.org\/10.1016\/j.vaccine.2022.09.090","DOI":"10.1016\/j.vaccine.2022.09.090"},{"key":"1513_CR16","doi-asserted-by":"publisher","unstructured":"Bianco A, Della Polla G, Angelillo S, Pelullo CP, Licata F, Angelillo IF. Parental COVID-19 vaccine hesitancy: a cross-sectional survey in Italy. Expert Rev Vaccines. Apr 2022;21(4):541\u20137. https:\/\/doi.org\/10.1080\/14760584.2022.2023013","DOI":"10.1080\/14760584.2022.2023013"},{"key":"1513_CR17","doi-asserted-by":"publisher","unstructured":"Fisher CB, Bragard E, Jaber R, Gray A. COVID-19 vaccine hesitancy among parents of children under five years in the United States. Vaccines (Basel). Aug 2022;10(8). https:\/\/doi.org\/10.3390\/vaccines10081313","DOI":"10.3390\/vaccines10081313"},{"issue":"7","key":"1513_CR18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/vaccines10071155","volume":"10","author":"JB Krakowczyk","year":"2022","unstructured":"Krakowczyk JB, Bauerle A, Pape L, Kaup T, Nulle L, Teufel M, et al. COVID-19 vaccine for children: vaccination willingness of parents and its Associated Factors-A Network Analysis. Vaccines (Basel). 2022;10(7):20. https:\/\/doi.org\/10.3390\/vaccines10071155","journal-title":"Vaccines (Basel)"},{"key":"1513_CR19","doi-asserted-by":"publisher","unstructured":"Letterie MC, Patrick SW, Halvorson AE, Dupont WD, Carroll KN, Zickafoose JS, et al. Factors Associated with parental COVID-19 Vaccination Acceptance. Clin Pediatr (Phila). Jun 2022;61:5\u20136. https:\/\/doi.org\/10.1177\/00099228221084829","DOI":"10.1177\/00099228221084829"},{"key":"1513_CR20","doi-asserted-by":"publisher","unstructured":"Tang S, Liu X, Jia Y, Chen H, Zheng P, Fu H, et al. Education level modifies parental hesitancy about COVID-19 vaccinations for their children. Vaccine. Jan 2023;41(2):496\u2013503. https:\/\/doi.org\/10.1016\/j.vaccine.2022.11.060","DOI":"10.1016\/j.vaccine.2022.11.060"},{"key":"1513_CR21","doi-asserted-by":"publisher","unstructured":"Kitro A, Sirikul W, Dilokkhamaruk E, Sumitmoh G, Pasirayut S, Wongcharoen A, et al. COVID-19 vaccine hesitancy and influential factors among thai parents and guardians to vaccinate their children. Vaccine X. Aug 2022;11:100182. https:\/\/doi.org\/10.1016\/j.jvacx.2022.100182","DOI":"10.1016\/j.jvacx.2022.100182"},{"key":"1513_CR22","doi-asserted-by":"publisher","unstructured":"Zhou X, Wang S, Zhang K, Chen S, Chan PS, Fang Y, et al. Changes in parents\u2019 COVID-19 vaccine hesitancy for children aged 3\u201317 years before and after the rollout of the National Childhood COVID-19 Vaccination Program in China: repeated cross-sectional surveys. Vaccines (Basel). Sep 2022;10(9). https:\/\/doi.org\/10.3390\/vaccines10091478","DOI":"10.3390\/vaccines10091478"},{"key":"1513_CR23","doi-asserted-by":"publisher","unstructured":"Lau EYH, Li JB, King Chung Chan D. Intention to vaccinate young children against COVID-19: a large-scale survey of Hong Kong parents. Hum Vaccin Immunother. Nov 30 2022;18(5):2065838. https:\/\/doi.org\/10.1080\/21645515.2022.2065838","DOI":"10.1080\/21645515.2022.2065838"},{"key":"1513_CR24","doi-asserted-by":"publisher","unstructured":"Willis DE, Schootman M, Shah SK, Reece S, Selig JP, Andersen JA, et al. Parent\/guardian intentions to vaccinate children against COVID-19 in the United States. Hum Vaccin Immunother. Nov 30 2022;18(5):2071078. https:\/\/doi.org\/10.1080\/21645515.2022.2071078","DOI":"10.1080\/21645515.2022.2071078"},{"key":"1513_CR25","doi-asserted-by":"publisher","unstructured":"Takahashi Y, Ishitsuka K, Sampei M, Okawa S, Hosokawa Y, Ishiguro A, et al. COVID-19 vaccine literacy and vaccine hesitancy among pregnant women and mothers of young children in Japan. Vaccine. Nov 2022;40(47):6849\u20136856. https:\/\/doi.org\/10.1016\/j.vaccine.2022.09.094","DOI":"10.1016\/j.vaccine.2022.09.094"},{"key":"1513_CR26","doi-asserted-by":"publisher","unstructured":"Humble RM, Sell H, Wilson S, Sadarangani M, Bettinger JA, Meyer SB, et al. Parents\u2019 perceptions on COVID-19 vaccination as the new routine for their children \u2264 11 years old. Prev Med. Aug 2022;161:107125. https:\/\/doi.org\/10.1016\/j.ypmed.2022.107125","DOI":"10.1016\/j.ypmed.2022.107125"},{"key":"1513_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/00099228221084829","volume":"61","author":"MC Letterie","year":"2022","unstructured":"Letterie MC, Patrick SW, Halvorson AE, Dupont WD, Carroll KN, Zickafoose JS, et al. Factors Associated with parental COVID-19 Vaccination Acceptance. Clin Pediatr. 2022;61:5\u20136.","journal-title":"Clin Pediatr"},{"key":"1513_CR28","doi-asserted-by":"publisher","unstructured":"Green MS, Peer V, Magid A, Hagani N, Anis E, Nitzan D. Gender differences in adverse events following the Pfizer-BioNTech COVID-19 Vaccine. Vaccines (Basel). Feb 2022;10(2). https:\/\/doi.org\/10.3390\/vaccines10020233","DOI":"10.3390\/vaccines10020233"},{"issue":"10","key":"1513_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/vaccines9101192","volume":"9","author":"M Babicki","year":"2021","unstructured":"Babicki M, Pokorna-Kalwak D, Doniec Z, Mastalerz-Migas A. Attitudes of parents with regard to vaccination of children against COVID-19 in Poland. A Nationwide Online Survey. Vaccines (Basel). 2021;9(10):17. https:\/\/doi.org\/10.3390\/vaccines9101192","journal-title":"Vaccines (Basel)"},{"key":"1513_CR30","doi-asserted-by":"publisher","unstructured":"Mangat C, Rich J, Sanghavi D, Schmidt R, Milosavljevic N, Linh T, et al. Parents\u2019 perspective on COVID-19 vaccine in children 6 months through 4 years: a cross-sectional study from Northwest Wisconsin. BMJ Open. Sep 17 2022;12(9):e065453. https:\/\/doi.org\/10.1136\/bmjopen-2022-065453","DOI":"10.1136\/bmjopen-2022-065453"},{"key":"1513_CR31","doi-asserted-by":"publisher","unstructured":"Bell S, Clarke R, Mounier-Jack S, Walker JL, Paterson P. Parents\u2019 and guardians\u2019 views on the acceptability of a future COVID-19 vaccine: a multi-methods study in England. Vaccine. Nov 2020;38(49):7789\u20137798. https:\/\/doi.org\/10.1016\/j.vaccine.2020.10.027","DOI":"10.1016\/j.vaccine.2020.10.027"},{"issue":"12","key":"1513_CR32","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/S1473-3099(21)00319-4","volume":"21","author":"B Han","year":"2021","unstructured":"Han B, Song Y, Li C, Yang W, Ma Q, Jiang Z, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1\/2 clinical trial. Lancet Infect Dis. 2021;21(12):1645\u201353.","journal-title":"Lancet Infect Dis"},{"issue":"21","key":"1513_CR33","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1056\/NEJMoa2203315","volume":"386","author":"CB Creech","year":"2022","unstructured":"Creech CB, Anderson E, Berthaud V, Yildirim I, Atz AM, Melendez Baez I, et al. Evaluation of mRNA-1273 Covid-19 vaccine in children 6 to 11 years of age. N Engl J Med. 2022;386(21):2011\u201323.","journal-title":"N Engl J Med"},{"issue":"3","key":"1513_CR34","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1056\/NEJMoa2107456","volume":"385","author":"RW Frenck Jr","year":"2021","unstructured":"Frenck RW Jr, Klein NP, Kitchin N, Gurtman A, Absalon J, Lockhart S, et al. Safety, immunogenicity, and efficacy of the BNT162b2 Covid-19 vaccine in adolescents. N Engl J Med. 2021;385(3):239\u201350.","journal-title":"N Engl J Med"},{"issue":"2","key":"1513_CR35","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S1473-3099(21)00462-X","volume":"22","author":"S Xia","year":"2022","unstructured":"Xia S, Zhang Y, Wang Y, Wang H, Yang Y, Gao GF, et al. Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1\/2 trial. Lancet Infect Dis. 2022;22(2):196\u2013208.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"1513_CR36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S1473-3099(20)30831-8","volume":"21","author":"S Xia","year":"2021","unstructured":"Xia S, Zhang Y, Wang Y, Wang H, Yang Y, Gao GF, et al. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1\/2 trial. Lancet Infect Dis. 2021;21(1):39\u201351.","journal-title":"Lancet Infect Dis"},{"key":"1513_CR37","doi-asserted-by":"publisher","unstructured":"Lara D, Young T, Del Toro K, Chan V, Ianiro C, Hunt K, et al. Acute fulminant myocarditis in a pediatric patient with COVID-19 infection. Pediatrics. Aug 2020;146(2). https:\/\/doi.org\/10.1542\/peds.2020-1509","DOI":"10.1542\/peds.2020-1509"},{"key":"1513_CR38","doi-asserted-by":"publisher","unstructured":"Trogen B, Gonzalez FJ, Shust GF. COVID-19-associated myocarditis in an adolescent. Pediatr Infect Dis J. Aug 2020;39(8):e204-e205. https:\/\/doi.org\/10.1097\/INF.0000000000002788","DOI":"10.1097\/INF.0000000000002788"},{"key":"1513_CR39","doi-asserted-by":"publisher","unstructured":"Bozkurt B, Kamat I, Hotez PJ. Myocarditis with COVID-19 mRNA vaccines. Circulation. Aug 2021;144(6):471\u2013484. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.056135","DOI":"10.1161\/CIRCULATIONAHA.121.056135"},{"issue":"10","key":"1513_CR40","doi-asserted-by":"publisher","first-page":"e360","DOI":"10.1097\/INF.0000000000003235","volume":"40","author":"O Snapiri","year":"2021","unstructured":"Snapiri O, Rosenberg Danziger C, Shirman N, Weissbach A, Lowenthal A, Ayalon I, et al. Transient Cardiac Injury in Adolescents receiving the BNT162b2 mRNA COVID-19 vaccine. Pediatr Infect Dis J. 2021;40(10):e360\u2013e. https:\/\/doi.org\/10.1097\/INF.0000000000003235","journal-title":"Pediatr Infect Dis J"},{"key":"1513_CR41","doi-asserted-by":"publisher","unstructured":"Minocha PK, Better D, Singh RK, Hoque T. Recurrence of Acute Myocarditis temporally Associated with receipt of the mRNA coronavirus Disease 2019 (COVID-19) vaccine in a male adolescent. J Pediatr. Nov 2021;238:321\u20133. https:\/\/doi.org\/10.1016\/j.jpeds.2021.06.035","DOI":"10.1016\/j.jpeds.2021.06.035"},{"key":"1513_CR42","doi-asserted-by":"publisher","unstructured":"Hadley SM, Prakash A, Baker AL, de Ferranti SD, Newburger JW, Friedman KG, et al. Follow-up cardiac magnetic resonance in children with vaccine-associated myocarditis. Eur J Pediatr. Jul 2022;181(7):2879\u201383. https:\/\/doi.org\/10.1007\/s00431-022-04482-z","DOI":"10.1007\/s00431-022-04482-z"},{"key":"1513_CR43","doi-asserted-by":"publisher","unstructured":"Patel T, Kelleman M, West Z, Peter A, Dove M, Butto A, et al. Comparison of multisystem inflammatory syndrome in children-related myocarditis, classic viral myocarditis, and COVID-19 vaccine-related myocarditis in children. J Am Heart Assoc. May 2022;11(9):e024393. https:\/\/doi.org\/10.1161\/JAHA.121.024393","DOI":"10.1161\/JAHA.121.024393"},{"key":"1513_CR44","doi-asserted-by":"publisher","unstructured":"Rostad CA, Chahroudi A, Mantus G, Lapp SA, Teherani M, Macoy L, et al. Quantitative SARS-CoV-2 serology in children with multisystem inflammatory syndrome (MIS-C). Pediatrics. Dec 2020;146(6). https:\/\/doi.org\/10.1542\/peds.2020-018242","DOI":"10.1542\/peds.2020-018242"},{"issue":"3","key":"1513_CR45","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1097\/INF.0000000000003432","volume":"41","author":"R Yalcinkaya","year":"2022","unstructured":"Yalcinkaya R, Oz FN, Polat M, Ucan B, Teke TA, Kaman A, et al. A case of Multisystem Inflammatory Syndrome in a 12-Year-old male after COVID-19 mRNA vaccine. Pediatr Infect Dis J. 2022;41(3):e87\u2013e. https:\/\/doi.org\/10.1097\/INF.0000000000003432","journal-title":"Pediatr Infect Dis J"},{"key":"1513_CR46","doi-asserted-by":"publisher","unstructured":"Chai Q, Nygaard U, Schmidt RC, Zaremba T, Moller AM, Thorvig CM. Multisystem inflammatory syndrome in a male adolescent after his second Pfizer-BioNTech COVID-19 vaccine. Acta Paediatr. Jan 2022;111(1):125\u20137. https:\/\/doi.org\/10.1111\/apa.16141","DOI":"10.1111\/apa.16141"},{"key":"1513_CR47","doi-asserted-by":"publisher","unstructured":"Levy M, Recher M, Hubert H, Javouhey E, Flechelles O, Leteurtre S, et al. Multisystem inflammatory syndrome in children by COVID-19 vaccination status of adolescents in France. JAMA. Jan 2022;327(3):281\u2013283. https:\/\/doi.org\/10.1001\/jama.2021.23262","DOI":"10.1001\/jama.2021.23262"},{"key":"1513_CR48","doi-asserted-by":"publisher","unstructured":"Nygaard U, Holm M, Hartling UB, Glenthoj J, Schmidt LS, Nordly SB, et al. Incidence and clinical phenotype of multisystem inflammatory syndrome in children after infection with the SARS-CoV-2 delta variant by vaccination status: a danish nationwide prospective cohort study. Lancet Child Adolesc Health. Jul 2022;6(7):459\u201365. https:\/\/doi.org\/10.1016\/S2352-4642(22)00100-6","DOI":"10.1016\/S2352-4642(22)00100-6"},{"issue":"18","key":"1513_CR49","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1056\/NEJMoa2209367","volume":"387","author":"EJ Anderson","year":"2022","unstructured":"Anderson EJ, Creech CB, Berthaud V, Piramzadian A, Johnson KA, Zervos M, et al. Evaluation of mRNA-1273 vaccine in children 6 months to 5 years of age. N Engl J Med. 2022;387(18):1673\u201387.","journal-title":"N Engl J Med"},{"issue":"24","key":"1513_CR50","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1056\/NEJMoa2109522","volume":"385","author":"K Ali","year":"2021","unstructured":"Ali K, Berman G, Zhou H, Deng W, Faughnan V, Coronado-Voges M, et al. Evaluation of mRNA-1273 SARS-CoV-2 vaccine in adolescents. N Engl J Med. 2021;385(24):2241\u201351.","journal-title":"N Engl J Med"},{"issue":"3","key":"1513_CR51","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nri2508","volume":"9","author":"C-A Siegrist","year":"2009","unstructured":"Siegrist C-A, Aspinall R. B-cell responses to vaccination at the extremes of age. Nat Rev Immunol. 2009;9(3):185\u201394.","journal-title":"Nat Rev Immunol"},{"key":"1513_CR52","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.3389\/fneur.2021.805643","volume":"12","author":"G Singh","year":"2022","unstructured":"Singh G, Tucker EW, Rohlwink UK. Infection in the developing brain: the role of unique systemic Immune Vulnerabilities. Front Neurol. 2022;12:2659.","journal-title":"Front Neurol"},{"issue":"1","key":"1513_CR53","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa2116298","volume":"386","author":"EB Walter","year":"2022","unstructured":"Walter EB, Talaat KR, Sabharwal C, Gurtman A, Lockhart S, Paulsen GC, et al. Evaluation of the BNT162b2 Covid-19 vaccine in children 5 to 11 years of age. N Engl J Med. 2022;386(1):35\u201346.","journal-title":"N Engl J Med"},{"key":"1513_CR54","doi-asserted-by":"publisher","unstructured":"Hu J, Peng P, Cao X, Wu K, Chen J, Wang K, et al. Increased immune escape of the new SARS-CoV-2 variant of concern Omicron. Cell Mol Immunol. Feb 2022;19(2):293\u20135. https:\/\/doi.org\/10.1038\/s41423-021-00836-z","DOI":"10.1038\/s41423-021-00836-z"},{"key":"1513_CR55","doi-asserted-by":"publisher","unstructured":"Cohen-Stavi CJ, Magen O, Barda N, Yaron S, Peretz A, Netzer D, et al. BNT162b2 vaccine effectiveness against Omicron in Children 5 to 11 years of age. N Engl J Med. Jul 21 2022;387(3):227\u201336. https:\/\/doi.org\/10.1056\/NEJMoa2205011","DOI":"10.1056\/NEJMoa2205011"},{"key":"1513_CR56","doi-asserted-by":"publisher","unstructured":"Piche-Renaud PP, Swayze S, Buchan SA, Wilson SE, Austin PC, Morris SK, et al. COVID-19 vaccine effectiveness against Omicron infection and hospitalization. Pediatrics. Mar 2023;151(4):e2022059513. https:\/\/doi.org\/10.1542\/peds.2022-059513","DOI":"10.1542\/peds.2022-059513"},{"key":"1513_CR57","doi-asserted-by":"publisher","unstructured":"Fleming-Dutra KE, Britton A, Shang N, Derado G, Link-Gelles R, Accorsi EK, et al. Association of prior BNT162b2 COVID-19 vaccination with symptomatic SARS-CoV-2 infection in children and adolescents during Omicron predominance. JAMA. Jun 2022;327(22):2210\u20132219. https:\/\/doi.org\/10.1001\/jama.2022.7493","DOI":"10.1001\/jama.2022.7493"},{"key":"1513_CR58","doi-asserted-by":"publisher","unstructured":"Tan SHX, Cook AR, Heng D, Ong B, Lye DC, Tan KB. Effectiveness of BNT162b2 vaccine against Omicron in children 5 to 11 years of age. N Engl J Med. Aug 2022;387(6):525\u201332. https:\/\/doi.org\/10.1056\/NEJMoa2203209","DOI":"10.1056\/NEJMoa2203209"},{"key":"1513_CR59","doi-asserted-by":"publisher","unstructured":"Price AM, Olson SM, Newhams MM, Halasa NB, Boom JA, Sahni LC, et al. BNT162b2 protection against the Omicron variant in children and adolescents. N Engl J Med. May 2022;386(20):1899\u2013909. https:\/\/doi.org\/10.1056\/NEJMoa2202826","DOI":"10.1056\/NEJMoa2202826"},{"key":"1513_CR60","doi-asserted-by":"crossref","unstructured":"Dorabawila V, Hoefer D, Bauer UE, Bassett M, Lutterloh E, Rosenberg E. Effectiveness of the BNT162b2 vaccine among children 5\u201311 and 12\u201317 years in New York after the emergence of the Omicron variant, MedRxiv, p. 2022.02. 25.22271454, 2022.","DOI":"10.1101\/2022.02.25.22271454"},{"key":"1513_CR61","doi-asserted-by":"publisher","unstructured":"Sacco C, Manso MD, Mateo-Urdiales A, Rota MC, Petrone D, Riccardo F, et al. Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5\u201311 years in Italy: a retrospective analysis of January-April, 2022. Lancet. Jul 2022;400(10346):97\u2013103. https:\/\/doi.org\/10.1016\/S0140-6736(22)01185-0","DOI":"10.1016\/S0140-6736(22)01185-0"},{"key":"1513_CR62","doi-asserted-by":"publisher","unstructured":"Leung D, Rosa Duque JS, Yip KM, So HK, Wong WHS, Lau YL. \u201cEffectiveness of BNT162b2 and CoronaVac in children and adolescents against SARS-CoV-2 infection during Omicron BA.2 wave in Hong Kong. Commun Med (Lond). Jan 2023;3(1):3. https:\/\/doi.org\/10.1038\/s43856-022-00233-1","DOI":"10.1038\/s43856-022-00233-1"},{"key":"1513_CR63","doi-asserted-by":"publisher","unstructured":"Reis BY, Barda N, Leshchinsky M, Kepten E, Hernan MA, Lipsitch M, et al. Effectiveness of BNT162b2 vaccine against Delta variant in adolescents. N Engl J Med. Nov 2021;385(22):2101\u20133. https:\/\/doi.org\/10.1056\/NEJMc2114290","DOI":"10.1056\/NEJMc2114290"},{"key":"1513_CR64","doi-asserted-by":"publisher","unstructured":"Olson SM, Newhams MM, Halasa NB, Price AM, Boom JA, Sahni LC, et al. Effectiveness of BNT162b2 vaccine against critical Covid-19 in adolescents. N Engl J Med. Feb 2022;386(8):713\u201323. https:\/\/doi.org\/10.1056\/NEJMoa2117995","DOI":"10.1056\/NEJMoa2117995"},{"key":"1513_CR65","doi-asserted-by":"publisher","unstructured":"Oliveira CR, Niccolai LM, Sheikha H, Elmansy L, Kalinich CC, Grubaugh ND, et al. Assessment of clinical effectiveness of BNT162b2 COVID-19 vaccine in US adolescents. JAMA Netw Open. Mar 2022;5(3):e220935. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.0935","DOI":"10.1001\/jamanetworkopen.2022.0935"},{"key":"1513_CR66","doi-asserted-by":"publisher","unstructured":"Link-Gelles R, Levy ME, Gaglani M, Irving SA, Stockwell M, Dascomb K, et al. Effectiveness of 2, 3, and 4 COVID-19 mRNA vaccine doses among immunocompetent adults during periods when SARS-CoV-2 Omicron BA.1 and BA.2\/BA.2.12.1 sublineages predominated - VISION network, 10 states, December 2021-June 2022. MMWR Morb Mortal Wkly Rep. Jul 2022;71(29):931\u2013939. https:\/\/doi.org\/10.15585\/mmwr.mm7129e1","DOI":"10.15585\/mmwr.mm7129e1"},{"key":"1513_CR67","doi-asserted-by":"publisher","unstructured":"Chalkias S, Harper C, Vrbicky K, Walsh SR, Essink B, Brosz A, et al. A Bivalent Omicron-Containing booster vaccine against Covid-19. N Engl J Med. Oct 6 2022;387:1279\u201391. https:\/\/doi.org\/10.1056\/NEJMoa2208343","DOI":"10.1056\/NEJMoa2208343"},{"key":"1513_CR68","doi-asserted-by":"publisher","first-page":"977972","DOI":"10.3389\/fimmu.2022.977972","volume":"13","author":"Z Wei","year":"2022","unstructured":"Wei Z, He J, Wang C, Bao J, Leng T, Chen F. The importance of booster vaccination in the context of Omicron wave. Front Immunol. 2022;13:977972. https:\/\/doi.org\/10.3389\/fimmu.2022.977972","journal-title":"Front Immunol"},{"key":"1513_CR69","doi-asserted-by":"crossref","unstructured":"Hause AM. Safety Monitoring of Bivalent COVID-19 mRNA vaccine booster doses among children aged 5\u201311 Years\u2014United States, October 12\u2013January 1, 2023, MMWR Morb Mortal Wkly Rep, vol. 72, 2023.","DOI":"10.15585\/mmwr.mm7202a5"},{"issue":"44","key":"1513_CR70","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.15585\/mmwr.mm7144a3","volume":"71","author":"AM Hause","year":"2022","unstructured":"Hause AM, Marquez P, Zhang B, Myers TR, Gee J, Su JR, et al. Safety monitoring of bivalent COVID-19 mRNA vaccine booster doses among persons aged \u2265 12 years\u2014United States, August 31\u2013October 23, 2022. Morb Mortal Wkly Rep. 2022;71(44):1401\u20136.","journal-title":"Morb Mortal Wkly Rep"},{"key":"1513_CR71","unstructured":"The American College of Obstetricians and Gynecologists. COVID-19 vaccination considerations for obstetric\u2013Gynecologic care. https:\/\/www.acog.org\/clinical\/clinical-guidance\/practice-advisory\/articles\/2020\/12\/covid-19-vaccination-considerations-for-obstetric-gynecologic-care?utm_source=redirect&utm_medium=web&utm_campaign=int."},{"key":"1513_CR72","unstructured":"Centers for Disease Control and Prevention. Interim clinical considerations for Use of COVID-19 vaccines currently approved or authorized in the United States. https:\/\/www.cdc.gov\/vaccines\/covid-19\/clinical-considerations\/interim-considerations-us.html"},{"key":"1513_CR73","doi-asserted-by":"publisher","unstructured":"Halasa NB, Olson SM, Staat MA, Newhams MM, Price AM, Boom JA, et al. Effectiveness of maternal vaccination with mRNA COVID-19 vaccine during pregnancy against COVID-19-Associated hospitalization in infants aged < 6 months \u2013 17 states, July 2021-January 2022. MMWR Morb Mortal Wkly Rep. Feb 2022;71(7):264\u201370. https:\/\/doi.org\/10.15585\/mmwr.mm7107e3","DOI":"10.15585\/mmwr.mm7107e3"},{"key":"1513_CR74","doi-asserted-by":"publisher","unstructured":"Burns MD, Muir C, Atyeo C, Davis JP, Demidkin S, Akinwunmi B, et al. Relationship between anti-spike antibodies and risk of SARS-CoV-2 infection in infants born to COVID-19 vaccinated mothers. Vaccines (Basel). Oct 2022;10(10):1696. https:\/\/doi.org\/10.3390\/vaccines10101696","DOI":"10.3390\/vaccines10101696"},{"issue":"2","key":"1513_CR75","doi-asserted-by":"publisher","first-page":"e1008559","DOI":"10.1371\/journal.pcbi.1008559","volume":"17","author":"I Dattner","year":"2021","unstructured":"Dattner I, Goldberg Y, Katriel G, Yaari R, Gal N, Miron Y, et al. The role of children in the spread of COVID-19: using household data from Bnei Brak, Israel, to estimate the relative susceptibility and infectivity of children. PLoS Comput Biol. 2021;17(2):e1008559.","journal-title":"PLoS Comput Biol"},{"key":"1513_CR76","doi-asserted-by":"crossref","unstructured":"Brandtzaeg P. Mucosal immunity: integration between mother and the breast-fed infant. Vaccine. 2003;21(24):3382\u20133388.","DOI":"10.1016\/S0264-410X(03)00338-4"},{"key":"1513_CR77","doi-asserted-by":"publisher","unstructured":"Posfay-Barbe KM, Wagner N, Gauthey M, Moussaoui D, Loevy N, Diana A, et al. COVID-19 in children and the dynamics of infection in families. Pediatrics. Aug 2020;146(2):e20201576. https:\/\/doi.org\/10.1542\/peds.2020-1576","DOI":"10.1542\/peds.2020-1576"},{"key":"1513_CR78","unstructured":"Food D, Administration, Vaccines, Committee RBPA. FDA briefing document: EUA amendment request for Pfizer-BioNTech COVID-19 vaccine for use in children 6 months through 4 years of age. 2022."},{"key":"1513_CR79","unstructured":"World Health Organization. The Pfizer BioNTech (BNT162b2) COVID-19 vaccine: what you need to know. https:\/\/www.who.int\/news-room\/feature-stories\/detail\/who-can-take-the-pfizer-biontech-covid-19--vaccine-what-you-need-to-know"},{"key":"1513_CR80","unstructured":"World Health Organization. The Moderna COVID-19 (mRNA-1273) vaccine: what you need to know. https:\/\/www.who.int\/news-room\/feature-stories\/detail\/the-moderna-covid-19-mrna-1273-vaccine-what-you-need-to-know"},{"key":"1513_CR81","unstructured":"Food US. and Drug Administration. Coronavirus (COVID-19) update: FDA authorizes updated (bivalent) COVID-19 vaccines for children down to 6 months of age. https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-authorizes-updated-bivalent-covid-19-vaccines-children-down-6-months"},{"key":"1513_CR82","unstructured":"Centers for Disease Control and Prevention. Stay up to date with COVID-19 vaccines including boosters. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/stay-up-to-date.html#2nd-dose"},{"key":"1513_CR83","unstructured":"European Medicines Agency. Comirnaty. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/comirnaty"},{"key":"1513_CR84","unstructured":"European Medicines Agency. Spikevax (previously COVID-19 vaccine Moderna) https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/spikevax"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-023-01513-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-023-01513-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-023-01513-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T03:33:37Z","timestamp":1700624017000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-023-01513-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,25]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1513"],"URL":"https:\/\/doi.org\/10.1186\/s13052-023-01513-9","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,25]]},"assertion":[{"value":"25 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"103"}}